Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)
USD 2.16
(0.46%)
USD 2.16
(0.46%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 986.7 Million CNY | 14.49% |
| 2022 | 861.79 Million CNY | 12.05% |
| 2021 | 769.14 Million CNY | 16.24% |
| 2020 | 661.7 Million CNY | 5.78% |
| 2019 | 625.56 Million CNY | 11.37% |
| 2018 | 561.67 Million CNY | 17.98% |
| 2017 | 476.07 Million CNY | 12.7% |
| 2016 | 422.42 Million CNY | -6.43% |
| 2015 | 451.44 Million CNY | 26.17% |
| 2014 | 357.8 Million CNY | 1.71% |
| 2013 | 351.79 Million CNY | -20.28% |
| 2012 | 441.29 Million CNY | 78.19% |
| 2011 | 247.64 Million CNY | -15.56% |
| 2010 | 293.28 Million CNY | 13.76% |
| 2009 | 257.81 Million CNY | 41.6% |
| 2008 | 182.08 Million CNY | 350.04% |
| 2007 | -72.81 Million CNY | 80.72% |
| 2006 | -377.76 Million CNY | -567.6% |
| 2005 | 80.78 Million CNY | 26.17% |
| 2004 | 64.03 Million CNY | -25.94% |
| 2003 | 86.45 Million CNY | 1.58% |
| 2002 | 85.11 Million CNY | 32.08% |
| 2001 | 64.44 Million CNY | -25.48% |
| 2000 | 86.47 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 146.13 Million CNY | -45.95% |
| 2024 Q2 | 270.39 Million CNY | -30.19% |
| 2024 Q1 | 387.32 Million CNY | 201.39% |
| 2023 FY | 986.7 Million CNY | 14.49% |
| 2023 Q3 | 135.7 Million CNY | -57.82% |
| 2023 Q4 | 128.51 Million CNY | -5.29% |
| 2023 Q1 | 400.78 Million CNY | 201.72% |
| 2023 Q2 | 321.7 Million CNY | -19.73% |
| 2022 FY | 861.79 Million CNY | 12.05% |
| 2022 Q1 | 199.6 Million CNY | 85.45% |
| 2022 Q4 | 132.83 Million CNY | -48.94% |
| 2022 Q3 | 260.17 Million CNY | -3.35% |
| 2022 Q2 | 269.18 Million CNY | 34.86% |
| 2021 Q3 | 198.96 Million CNY | -20.29% |
| 2021 FY | 769.14 Million CNY | 16.24% |
| 2021 Q4 | 107.63 Million CNY | -45.9% |
| 2021 Q1 | 212.94 Million CNY | 15.17% |
| 2021 Q2 | 249.6 Million CNY | 17.21% |
| 2020 Q2 | 153.57 Million CNY | -9.6% |
| 2020 Q1 | 169.88 Million CNY | -5.88% |
| 2020 Q3 | 153.33 Million CNY | -0.15% |
| 2020 FY | 661.7 Million CNY | 5.78% |
| 2020 Q4 | 184.9 Million CNY | 20.58% |
| 2019 Q2 | 156.85 Million CNY | -17.45% |
| 2019 FY | 625.56 Million CNY | 11.37% |
| 2019 Q3 | 98.2 Million CNY | -37.39% |
| 2019 Q4 | 180.5 Million CNY | 83.81% |
| 2019 Q1 | 190 Million CNY | 18.18% |
| 2018 Q3 | 87.41 Million CNY | -37.62% |
| 2018 FY | 561.67 Million CNY | 17.98% |
| 2018 Q4 | 160.77 Million CNY | 83.92% |
| 2018 Q2 | 140.12 Million CNY | -19.18% |
| 2018 Q1 | 173.36 Million CNY | 48.72% |
| 2017 Q4 | 116.57 Million CNY | 42.16% |
| 2017 FY | 476.07 Million CNY | 12.7% |
| 2017 Q1 | 133.74 Million CNY | 82.84% |
| 2017 Q2 | 143.75 Million CNY | 7.48% |
| 2017 Q3 | 82 Million CNY | -42.96% |
| 2016 Q2 | 139.06 Million CNY | 16.29% |
| 2016 Q3 | 90.62 Million CNY | -34.83% |
| 2016 FY | 422.42 Million CNY | -6.43% |
| 2016 Q4 | 73.15 Million CNY | -19.29% |
| 2016 Q1 | 119.58 Million CNY | 2.72% |
| 2015 Q2 | 119.45 Million CNY | 0.04% |
| 2015 Q1 | 119.41 Million CNY | 18.27% |
| 2015 Q3 | 96.16 Million CNY | -19.49% |
| 2015 Q4 | 116.41 Million CNY | 21.05% |
| 2015 FY | 451.44 Million CNY | 26.17% |
| 2014 FY | 357.8 Million CNY | 1.71% |
| 2014 Q1 | 102.34 Million CNY | -10.99% |
| 2014 Q2 | 95.98 Million CNY | -6.21% |
| 2014 Q3 | 58.5 Million CNY | -39.05% |
| 2014 Q4 | 100.96 Million CNY | 72.56% |
| 2013 FY | 351.79 Million CNY | -20.28% |
| 2013 Q3 | 47.62 Million CNY | -32.66% |
| 2013 Q4 | 114.97 Million CNY | 141.41% |
| 2013 Q2 | 70.72 Million CNY | -40.3% |
| 2013 Q1 | 118.46 Million CNY | 69.1% |
| 2012 FY | 441.29 Million CNY | 78.19% |
| 2012 Q4 | 70.05 Million CNY | 38.93% |
| 2012 Q3 | 50.42 Million CNY | -70.82% |
| 2012 Q2 | 172.81 Million CNY | 16.76% |
| 2012 Q1 | 148 Million CNY | 146763.18% |
| 2011 Q4 | 100.77 Thousand CNY | -99.81% |
| 2011 Q1 | 117.61 Million CNY | 136.75% |
| 2011 Q3 | 52.58 Million CNY | -32.03% |
| 2011 Q2 | 77.35 Million CNY | -34.23% |
| 2011 FY | 247.64 Million CNY | -15.56% |
| 2010 Q4 | 49.67 Million CNY | -11.03% |
| 2010 Q3 | 55.83 Million CNY | -26.66% |
| 2010 Q2 | 76.13 Million CNY | -31.8% |
| 2010 Q1 | 111.63 Million CNY | 234.86% |
| 2010 FY | 293.28 Million CNY | 13.76% |
| 2009 FY | 257.81 Million CNY | 41.6% |
| 2009 Q4 | 33.33 Million CNY | -52.99% |
| 2009 Q1 | 91.64 Million CNY | 1765.36% |
| 2009 Q2 | 61.92 Million CNY | -32.43% |
| 2009 Q3 | 70.91 Million CNY | 14.53% |
| 2008 FY | 182.08 Million CNY | 350.04% |
| 2008 Q4 | 4.91 Million CNY | -83.72% |
| 2008 Q3 | 30.18 Million CNY | -69.29% |
| 2008 Q2 | 98.29 Million CNY | 101.91% |
| 2008 Q1 | 48.68 Million CNY | 142.73% |
| 2007 FY | -72.81 Million CNY | 80.72% |
| 2007 Q4 | -113.92 Million CNY | -487.6% |
| 2007 Q3 | -19.38 Million CNY | -155.22% |
| 2007 Q2 | 35.11 Million CNY | 38.34% |
| 2007 Q1 | 25.38 Million CNY | 106.15% |
| 2006 Q3 | -11.23 Million CNY | -152.17% |
| 2006 FY | -377.76 Million CNY | -567.6% |
| 2006 Q2 | 21.53 Million CNY | -12.3% |
| 2006 Q4 | -412.61 Million CNY | -3572.61% |
| 2006 Q1 | 24.55 Million CNY | -7.03% |
| 2005 Q4 | 26.41 Million CNY | 172.23% |
| 2005 Q3 | 9.7 Million CNY | -52.09% |
| 2005 Q2 | 20.25 Million CNY | -17.07% |
| 2005 Q1 | 24.42 Million CNY | 5224.44% |
| 2005 FY | 80.78 Million CNY | 26.17% |
| 2004 Q4 | -476.56 Thousand CNY | -105.74% |
| 2004 Q3 | 8.29 Million CNY | -74.08% |
| 2004 FY | 64.03 Million CNY | -25.94% |
| 2004 Q2 | 32.01 Million CNY | 32.28% |
| 2004 Q1 | 24.19 Million CNY | -3.25% |
| 2003 FY | 86.45 Million CNY | 1.58% |
| 2003 Q4 | 25.01 Million CNY | 324.12% |
| 2003 Q2 | 28.13 Million CNY | 2.59% |
| 2003 Q1 | 27.41 Million CNY | 810.41% |
| 2003 Q3 | 5.89 Million CNY | -79.04% |
| 2002 Q4 | 3.01 Million CNY | -90.03% |
| 2002 Q1 | 40.55 Million CNY | 0.0% |
| 2002 Q3 | 30.21 Million CNY | 166.65% |
| 2002 Q2 | 11.32 Million CNY | -72.07% |
| 2002 FY | 85.11 Million CNY | 32.08% |
| 2001 FY | 64.44 Million CNY | -25.48% |
| 2000 FY | 86.47 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|